Report Overview
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
The global Liquid Biopsy For Cancer Diagnostics market size was estimated at USD 3603.70 million in 2023 and is projected to reach USD 10319.19 million by 2032, exhibiting a CAGR of 12.40% during the forecast period.
North America Liquid Biopsy For Cancer Diagnostics market size was estimated at USD 1149.24 million in 2023, at a CAGR of 10.63% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Liquid Biopsy For Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liquid Biopsy For Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liquid Biopsy For Cancer Diagnostics market in any manner.
Global Liquid Biopsy For Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
F. Hoffman La Roche Ltd.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Illumina Inc.
The Menarini Group
Bio-Rad Laboratories Inc.
QIAGEN Inc.
Exact Sciences Corporation
Bio-Techne Corporation
ArcherDX Inc.
Neogenomics Laboratories Inc.
Guardant Health Inc.
Myriad Genetics Inc.
Foundation Medicine Inc.
Amoy Diagnostics Co. Ltd.
Biocartis Group NV
Market Segmentation (by Type)
Blood Test
Urine Test
Saliva Test
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Liquid Biopsy For Cancer Diagnostics Market
Overview of the regional outlook of the Liquid Biopsy For Cancer Diagnostics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Biopsy For Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Liquid Biopsy For Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liquid Biopsy For Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Liquid Biopsy For Cancer Diagnostics Segment by Type
1.2.2 Liquid Biopsy For Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liquid Biopsy For Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape
3.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Manufacturers (2019-2025)
3.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2025)
3.3 Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liquid Biopsy For Cancer Diagnostics Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Liquid Biopsy For Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Liquid Biopsy For Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Liquid Biopsy For Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liquid Biopsy For Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.1 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liquid Biopsy For Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Type (2019-2025)
6.3 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2019-2025)
6.4 Global Liquid Biopsy For Cancer Diagnostics Price by Type (2019-2025)
7 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Biopsy For Cancer Diagnostics Market Sales by Application (2019-2025)
7.3 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) by Application (2019-2025)
7.4 Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2025)
8 Liquid Biopsy For Cancer Diagnostics Market Consumption by Region
8.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liquid Biopsy For Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Liquid Biopsy For Cancer Diagnostics Market Production by Region
9.1 Global Production of Liquid Biopsy For Cancer Diagnostics by Region (2019-2025)
9.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2019-2025)
9.3 Global Liquid Biopsy For Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Liquid Biopsy For Cancer Diagnostics Production
9.4.1 North America Liquid Biopsy For Cancer Diagnostics Production Growth Rate (2019-2025)
9.4.2 North America Liquid Biopsy For Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Liquid Biopsy For Cancer Diagnostics Production
9.5.1 Europe Liquid Biopsy For Cancer Diagnostics Production Growth Rate (2019-2025)
9.5.2 Europe Liquid Biopsy For Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Liquid Biopsy For Cancer Diagnostics Production (2019-2025)
9.6.1 Japan Liquid Biopsy For Cancer Diagnostics Production Growth Rate (2019-2025)
9.6.2 Japan Liquid Biopsy For Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Liquid Biopsy For Cancer Diagnostics Production (2019-2025)
9.7.1 China Liquid Biopsy For Cancer Diagnostics Production Growth Rate (2019-2025)
9.7.2 China Liquid Biopsy For Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 F. Hoffman La Roche Ltd.
10.1.1 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
10.1.2 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
10.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.1.4 F. Hoffman La Roche Ltd. Business Overview
10.1.5 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
10.1.6 F. Hoffman La Roche Ltd. Recent Developments
10.2 Thermo Fisher Scientific Inc.
10.2.1 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.2.2 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.2.4 Thermo Fisher Scientific Inc. Business Overview
10.2.5 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
10.2.6 Thermo Fisher Scientific Inc. Recent Developments
10.3 Agilent Technologies Inc.
10.3.1 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.3.2 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
10.3.5 Agilent Technologies Inc. Business Overview
10.3.6 Agilent Technologies Inc. Recent Developments
10.4 Illumina Inc.
10.4.1 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.4.2 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.4.4 Illumina Inc. Business Overview
10.4.5 Illumina Inc. Recent Developments
10.5 The Menarini Group
10.5.1 The Menarini Group Liquid Biopsy For Cancer Diagnostics Basic Information
10.5.2 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Overview
10.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.5.4 The Menarini Group Business Overview
10.5.5 The Menarini Group Recent Developments
10.6 Bio-Rad Laboratories Inc.
10.6.1 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.6.2 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.6.4 Bio-Rad Laboratories Inc. Business Overview
10.6.5 Bio-Rad Laboratories Inc. Recent Developments
10.7 QIAGEN Inc.
10.7.1 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.7.2 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.7.4 QIAGEN Inc. Business Overview
10.7.5 QIAGEN Inc. Recent Developments
10.8 Exact Sciences Corporation
10.8.1 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
10.8.2 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
10.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.8.4 Exact Sciences Corporation Business Overview
10.8.5 Exact Sciences Corporation Recent Developments
10.9 Bio-Techne Corporation
10.9.1 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
10.9.2 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
10.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.9.4 Bio-Techne Corporation Business Overview
10.9.5 Bio-Techne Corporation Recent Developments
10.10 ArcherDX Inc.
10.10.1 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.10.2 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.10.4 ArcherDX Inc. Business Overview
10.10.5 ArcherDX Inc. Recent Developments
10.11 Neogenomics Laboratories Inc.
10.11.1 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.11.2 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.11.4 Neogenomics Laboratories Inc. Business Overview
10.11.5 Neogenomics Laboratories Inc. Recent Developments
10.12 Guardant Health Inc.
10.12.1 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.12.2 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.12.4 Guardant Health Inc. Business Overview
10.12.5 Guardant Health Inc. Recent Developments
10.13 Myriad Genetics Inc.
10.13.1 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.13.2 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.13.4 Myriad Genetics Inc. Business Overview
10.13.5 Myriad Genetics Inc. Recent Developments
10.14 Foundation Medicine Inc.
10.14.1 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
10.14.2 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
10.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.14.4 Foundation Medicine Inc. Business Overview
10.14.5 Foundation Medicine Inc. Recent Developments
10.15 Amoy Diagnostics Co. Ltd.
10.15.1 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
10.15.2 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
10.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.15.4 Amoy Diagnostics Co. Ltd. Business Overview
10.15.5 Amoy Diagnostics Co. Ltd. Recent Developments
10.16 Biocartis Group NV
10.16.1 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Basic Information
10.16.2 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Overview
10.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Market Performance
10.16.4 Biocartis Group NV Business Overview
10.16.5 Biocartis Group NV Recent Developments
11 Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
11.1 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast
11.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region
11.2.4 South America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Liquid Biopsy For Cancer Diagnostics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Liquid Biopsy For Cancer Diagnostics by Type (2025-2032)
12.1.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Liquid Biopsy For Cancer Diagnostics by Type (2025-2032)
12.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liquid Biopsy For Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Liquid Biopsy For Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2022)
Table 10. Global Market Liquid Biopsy For Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Liquid Biopsy For Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Liquid Biopsy For Cancer Diagnostics Product Type
Table 13. Global Liquid Biopsy For Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Liquid Biopsy For Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Liquid Biopsy For Cancer Diagnostics Market Challenges
Table 22. Global Liquid Biopsy For Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Type (2019-2025)
Table 25. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Type (2019-2025)
Table 26. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) by Type (2019-2025)
Table 27. Global Liquid Biopsy For Cancer Diagnostics Market Size Share by Type (2019-2025)
Table 28. Global Liquid Biopsy For Cancer Diagnostics Price (USD/Unit) by Type (2019-2025)
Table 29. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application
Table 31. Global Liquid Biopsy For Cancer Diagnostics Sales by Application (2019-2025) & (K Units)
Table 32. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application (2019-2025)
Table 33. Global Liquid Biopsy For Cancer Diagnostics Sales by Application (2019-2025) & (M USD)
Table 34. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application (2019-2025)
Table 35. Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2025)
Table 36. Global Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2025) & (K Units)
Table 37. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region (2019-2025)
Table 38. North America Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2025) & (K Units)
Table 39. Europe Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2025) & (K Units)
Table 41. South America Liquid Biopsy For Cancer Diagnostics Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales by Region (2019-2025) & (K Units)
Table 43. Global Liquid Biopsy For Cancer Diagnostics Production (K Units) by Region (2019-2025)
Table 44. Global Liquid Biopsy For Cancer Diagnostics Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Region (2019-2025)
Table 46. Global Liquid Biopsy For Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Liquid Biopsy For Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Liquid Biopsy For Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Liquid Biopsy For Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Liquid Biopsy For Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 52. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 53. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. F. Hoffman La Roche Ltd. Business Overview
Table 55. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 56. F. Hoffman La Roche Ltd. Recent Developments
Table 57. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 58. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 59. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Thermo Fisher Scientific Inc. Business Overview
Table 61. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 62. Thermo Fisher Scientific Inc. Recent Developments
Table 63. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 64. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 65. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
Table 67. Agilent Technologies Inc. Business Overview
Table 68. Agilent Technologies Inc. Recent Developments
Table 69. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 70. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 71. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Illumina Inc. Business Overview
Table 73. Illumina Inc. Recent Developments
Table 74. The Menarini Group Liquid Biopsy For Cancer Diagnostics Basic Information
Table 75. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Overview
Table 76. The Menarini Group Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. The Menarini Group Business Overview
Table 78. The Menarini Group Recent Developments
Table 79. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 80. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 81. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Bio-Rad Laboratories Inc. Business Overview
Table 83. Bio-Rad Laboratories Inc. Recent Developments
Table 84. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 85. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 86. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. QIAGEN Inc. Business Overview
Table 88. QIAGEN Inc. Recent Developments
Table 89. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
Table 90. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
Table 91. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Exact Sciences Corporation Business Overview
Table 93. Exact Sciences Corporation Recent Developments
Table 94. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
Table 95. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
Table 96. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Bio-Techne Corporation Business Overview
Table 98. Bio-Techne Corporation Recent Developments
Table 99. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 100. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 101. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. ArcherDX Inc. Business Overview
Table 103. ArcherDX Inc. Recent Developments
Table 104. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 105. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 106. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Neogenomics Laboratories Inc. Business Overview
Table 108. Neogenomics Laboratories Inc. Recent Developments
Table 109. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 110. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 111. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Guardant Health Inc. Business Overview
Table 113. Guardant Health Inc. Recent Developments
Table 114. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 115. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 116. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Myriad Genetics Inc. Business Overview
Table 118. Myriad Genetics Inc. Recent Developments
Table 119. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 120. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 121. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Foundation Medicine Inc. Business Overview
Table 123. Foundation Medicine Inc. Recent Developments
Table 124. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
Table 125. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
Table 126. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Amoy Diagnostics Co. Ltd. Business Overview
Table 128. Amoy Diagnostics Co. Ltd. Recent Developments
Table 129. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Basic Information
Table 130. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Overview
Table 131. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Biocartis Group NV Business Overview
Table 133. Biocartis Group NV Recent Developments
Table 134. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 135. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 137. North America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 139. Europe Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 141. Asia Pacific Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Liquid Biopsy For Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 143. South America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 147. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Liquid Biopsy For Cancer Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 149. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 150. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Liquid Biopsy For Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liquid Biopsy For Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Liquid Biopsy For Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Liquid Biopsy For Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Liquid Biopsy For Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Liquid Biopsy For Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Liquid Biopsy For Cancer Diagnostics by Type (2019-2025)
Figure 19. Sales Market Share of Liquid Biopsy For Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Liquid Biopsy For Cancer Diagnostics by Type (2019-2025)
Figure 21. Market Size Market Share of Liquid Biopsy For Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application
Figure 24. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application (2019-2025)
Figure 25. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application (2019-2025)
Figure 27. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2025)
Figure 29. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region (2019-2025)
Figure 30. North America Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Liquid Biopsy For Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Liquid Biopsy For Cancer Diagnostics Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Liquid Biopsy For Cancer Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Liquid Biopsy For Cancer Diagnostics Production Market Share by Region (2019-2025)
Figure 62. North America Liquid Biopsy For Cancer Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Liquid Biopsy For Cancer Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Liquid Biopsy For Cancer Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 65. China Liquid Biopsy For Cancer Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Liquid Biopsy For Cancer Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Liquid Biopsy For Cancer Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Application (2025-2032)
